Severe onset of newly diagnosed secondary immune thrombocytopenia in a 4-year-old patient as a complication of HHV-7 infection – A case report
DOI:
https://doi.org/10.12923/cipms-2026-0028Keywords:
immune thrombocytopenia, ITP, human herpesvirus 7, HHV-7Abstract
Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated thrombocytopenia. Viral infections are one of the most common triggers, particularly in children. However, the role of human herpesvirus 7 (HHV-7) in ITP pathogenesis has yet to be established. Here, we present the case of a previously healthy 4-year-old girl with severe hemorrhagic symptoms and a critically low platelet count of 2,000/µL. Additional laboratory tests confirmed an acute HHV-7 infection. Despite initial treatment with platelet transfusions and intravenous immunoglobulin, the patient's thrombocytopenia persisted, necessitating the introduction of glucocorticoids. The patient showed gradual clinical and hematological improvement, with complete resolution by day 19 of hospitalization. Other causes of secondary ITP, including malignancy and autoimmune diseases, were ruled out. This case suggests a possible association between HHV-7 infection and the onset of secondary ITP in children. The case underscores the importance of comprehensive viral diagnostics in pediatric patients with severe thrombocytopenia and emphasizes the need for further research on the role of HHV-7 in hematologic complications.
References
1. Verbeek R, Vandekerckhove L, Van Cleemput J. Update on human herpesvirus 7 pathogenesis and clinical aspects as a roadmap for future research. J Virol. 2024;98(6):e0043724. doi: 10.1128/jvi.00437-24.
2. Zhao M, Wang Y, Shen Y, Wei C, Zhang G, Sun L. A review of the roles of pathogens in Alzheimer's disease. Front Neurosci. 2024; 18:1439055. doi: 10.3389/fnins.2024.1439055.
3. Thakur Y, Meshram RJ, Taksande A. Diagnosis and management of immune thrombocytopenia in paediatrics: a comprehensive review. Cureus. 2024;16(9):e69635. doi: 10.7759/cureus.69635.
4. Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017; 16(6):620-632. doi: 10.1016/j.autrev.2017.04.012.
5. Martínez-Carballeira D, Bernardo Á, Caro A, Soto I, Gutiérrez L. Pathophysiology, clinical manifestations and diagnosis of immune thrombocytopenia: contextualization from a historical perspective. Hematol Rep. 2024;16(2):204-219. doi: 10.3390/hematolrep16020021.
6. Song JC, Liu SY, Zhu F, Wen AQ, Ma LH, Li WQ, Wu J, et al. Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China. Mil Med Res. 2020;7(1):15. doi: 10.1186/s40779-020-00244-w.
7. Shaw J, Kilpatrick K, Eisen M, Tarantino M. The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States. Platelets. 2020;31(3):307-314. doi: 10.1080/09537104.2019.1635687.
8. González-López TJ, Provan D, Bárez A, Bernardo-Gutiérrez A, Bernat S, Martínez-Carballeira D, et al. Primary and secondary immune thrombocytopenia (ITP): time for a rethink. Blood Rev. 2023;61:101112. doi: 10.1016/j.blre.2023.101112.
9. Mititelu A, Onisâi MC, Roșca A, Vlădăreanu AM. Current understanding of immune thrombocytopenia: a review of pathogenesis and treatment options. Int J Mol Sci. 2024;25(4):2163. doi: 10.3390/ijms25042163.
10. Gan G, Liu H, Liang Z, Zhang G, Liu X, Ma L. Vaccine-associated thrombocytopenia. Thromb Res. 2022;220:12-20. doi: 10.1016/j.thromres.2022.09.017.
11. Lim JH, Kim YK, Min SH, Kim SW, Lee YH, Lee JM. Epidemiology and viral etiology of pediatric immune thrombocytopenia through Korean public health data analysis. J Clin Med. 2021;10(7):1356. doi: 10.3390/jcm10071356.
12. Dongre A, Jameel PZ, Deshmukh M, Bhandarkar S. Immune thrombocytopenic purpura secondary to SARS-CoV-2 infection in a child with acute lymphoblastic leukaemia: a case report and review of literature. BMJ Case Rep. 2021;14(11):e245869. doi: 10.1136/bcr-2021-245869.
13. Abbasi F, Kaydani GA, Tahannezhad Z, Nakhaie M, Asnafi AA, Moradi M. Prevalence of cytomegalovirus and Epstein-Barr virus subclinical infection in patients with acute immune thrombocytopenic purpura. Int J Hematol Oncol Stem Cell Res. 2021;15(3):139-144. doi: 10.18502/ijhoscr.v15i3.6843.
14. Rama Krishna M, Gottam US, Mahendra N. Disseminated tuberculosis with severe immune thrombocytopenia. Respir Med Case Rep. 2019;27:100812. doi: 10.1016/j.rmcr.2019.02.013.
15. Algwaiz G, Alharbi A, Alsehaim K, Alahmari A, El Fakih R, Aljurf M. Hematologic manifestations of parvovirus B19 infection. Hematol Oncol Stem Cell Ther. 2023;16(4):316-322. doi: 10.56875/2589-0646.1031.
16. Kumar J, Sundaram V, Gupta K, Bhatia A, Kaur G, Dutta S. Congenital rubella syndrome as a possible cause for persistent thrombocytopenia in early infancy. Autopsy Case Rep. 2022;12: e2021386. doi: 10.4322/acr.2021.386.
17. Huang CE, Chang JJ, Wu YY, Huang SH, Chen WM, Hsu CC, et al. Different impacts of risk factors associated with thrombocytopenia in hepatitis B and C virus infection. Biomed J. 2022;45(5):788-797. doi: 10.1016/j.bj.2021.09.001.
18. Sandhya AS, Prajapat B. Thrombocytopenia in HIV patients coinfected with tuberculosis. J Family Med Prim Care. 2017;6(4):859-861. doi: 10.4103/jfmpc.jfmpc_250_17.
19. Onisâi M, Vlădăreanu AM, Iordan I, Bumbea H, Găman M, Ciufu C, et al. Primary, secondary or less frequent causes of immune thrombocytopenia: a case report. Exp Ther Med. 2021;22(4):1096. doi: 10.3892/etm.2021.10530.
20. Sato A, Nakagawa M, Nishizawa K, Narita T, Nishikawa R, Yamada A, et al. Thrombocytopenia after HHV-7 infection in DiGeorge syndrome. J Pediatr Hematol Oncol. 1999;21(2):171-172. doi: 10.1097/00043426-199903000-00018.
21. Yoshikawa T, Morooka M, Suga S, Niinomi Y, Kaneko T, Shinoda K, et al. Thrombocytopenia induced by primary HHV-6 infection. Acta Paediatr Jpn. 1998;40(3):278-281. doi: 10.1111/j.1442-200X.1998.tb01928.x.
22. Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966.
23. Łaguna P, Styczyński J, Kołtan S, Richert-Przygońska M, Karwacki M, Badowska W, et al. Pierwotna małopłytkowość immunologiczna – zalecenia postępowania. Hematol Edu. 2024;4(1-2):18-30. doi: 10.5603/hemedu.101676.
24. Cheng CN, Yang YN, Yeh YH, Chen LW, Chen JS, Lin YC. Predictors of remission in severe childhood immune thrombocytopenia. Diagnostics. 2023;13(3):341. doi: 10.3390/diagnostics13030341.
25. Ren X, Zhang M, Zhang X, Zhao P, Zhai W. Low-dose vs high-dose IVIG in newly diagnosed childhood ITP: systematic review. BMC Pediatr. 2024;24(1):199. doi: 10.1186/s12887-024-04677-3.
26. Denu RA, Matson DR, Davis MJ, Tedford NJ, Brichta CE, Diamond CA, Hoover-Regan ML. Association of ITP and T-lymphoblastic lymphoma in a pediatric patient. Case Rep Hematol. 2019;2019:1425151. doi: 10.1155/2019/1425151.
27. Winer ES, Safran H, Karaszewska B, Bauer S, Khan D, Doerfel S, et al. Eltrombopag for thrombocytopenia in patients with solid tumors receiving gemcitabine: phase 2 trial. Int J Hematol. 2017; 106(6):765-776. doi: 10.1007/s12185-017-2319-9.
28. Russo G, Parodi E, Farruggia P, Notarangelo LD, Perrotta S, Casale M, et al. Acute ITP in children: recommendations from Italian Association of Pediatric Hematology and Oncology. Blood Transfus. 2024;22(3):253-265. doi: 10.2450/BloodTransfus.501.
29. Neunert CE, Rose MJ. Romiplostim in pediatric immune thrombocytopenia: development and practice. Blood Adv. 2019;3(12):1907-1915. doi: 10.1182/bloodadvances.2019000279.
30. Harris EM, Hillier K, Al-Samkari H, Berbert L, Grace RF. Response to rituximab in children and adults with ITP. Res Pract Thromb Haemost. 2021;5(6):e12587. doi: 10.1002/rth2.12587.
31. Lucchini E, Zaja F, Bussel J. Rituximab in immune thrombo-cytopenia: role in 2019. Haematologica. 2019;104(6):1124-1135. doi: 10.3324/haematol.2019.218883.
32. Vianelli N, Auteri G, Buccisano F, Carrai V, Baldacci E, Clissa C, et al. Refractory primary immune thrombocytopenia: challenges and perspectives. Ann Hematol. 2022;101(5):963-978. doi: 10.1007/s00277-022-04786-y.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Zuzanna Skiba, Aleksander Siwek, Julia Kowalczyk, Adrian Kowalczyk, Paulina Deleszkiewicz-Jóźwik, Monika Lejman, Joanna Zawitkowska (Autor)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
